Priority 4 from the Psoriasis PSP
|UNCERTAINTY: What is the best way to treat the symptoms of psoriasis: itching, burning, redness, scaling and flaking? (JLA PSP Priority 4)|
|JLA question ID||0072/4|
|Explanatory note||Not available for this PSP|
Shahwan Evidence of no significant difference in mean baseline itch scores in patients with psoriasis or atopic dermatitis who need treatment with systemic therapies. Evidence that pruritus is a more significant component of psoriasis than previously recognised. Pruritus in psoriasis has been associated with occupational impairment, anxiety, depression, and has a negative impact on overall quality of life, mood, concentration, sleep, sexual desire, and appetite. Further research is needed.
Van Laarhoven Evidence that placebo can have a substantial effect in the treatment of itch in dermatological patients with chronic itch due to a variety of skin diseases including psoriasis. Further research needed.
|Health Research Classification System category||Skin|
|Extra information provided by this PSP|
|Original uncertainty examples||How can itching be controlled properly?|
|Submitted by||54 uncertainties were submitted around this question|
|PSP unique ID||0072|
|Total number of uncertainties identified by this PSP.||55 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)|
|Date of priority setting workshop||17 September 2018|